This is a routine governance filing with no immediate trading catalyst. The reduced evergreen provision (5% to 4%) marginally lowers future dilution risk, but the impact is negligible for near-term price action. Monitor the next quarterly filing for any changes in share count or compensation expense.
ORIC drugs
ORIC drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 23 $8.91entry
- T+1 · 5mo ago +5.84%α +5.88% · $9.43
- T+5 · 5mo ago +13.97%α +12.96% · $10.16
- T+20 · 4mo ago +16.95%α +15.79% · $10.42
- T+60 · 2mo ago +40.74%α +37.49% · $12.54
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
ORIC Pharmaceuticals filed an 8-K reporting the stockholder-approved amendment and restatement of its 2020 Equity Incentive Plan at the June 18, 2026 annual meeting. Key changes include reducing the annual evergreen increase from 5% to 4% of outstanding shares (removing the 2,656,500-share cap) and eliminating the ability to implement an exchange program. The filing also reports the re-election of directors Jacob M. Chacko, M.D. and Mardi C. Dier, ratification of KPMG as auditor, and an advisory vote supporting annual say-on-pay frequency. This is a routine governance filing with no material financial impact.
Key Facts
- Stockholders approved the amended and restated 2020 Equity Incentive Plan with 61,228,918 votes for, 27,264,875 against, and 1,212,463 abstentions.
- The annual evergreen provision was amended to reduce the annual increase from 5% to 4% of outstanding shares, removing the prior fixed cap of 2,656,500 shares.
- The plan now caps incentive stock option issuance at 10,000,000 shares.
- The administrator's ability to implement an exchange program (cancelling/re-pricing underwater options) was eliminated.
- Directors Jacob M. Chacko, M.D. (89,298,150 for) and Mardi C. Dier (82,007,899 for) were re-elected as Class III directors.
- KPMG LLP was ratified as independent auditor for FY2026 (94,536,096 for, 34,641 against).
- Advisory vote on executive compensation passed with 88,453,809 for, 1,250,074 against.
- Stockholders selected 'every one year' as the frequency for future advisory votes on executive compensation (89,392,979 for one year).
- 94,571,281 shares (91.36% of outstanding) were represented at the meeting.
Financial Impact
No financial figures reported. The plan amendment reduces potential annual dilution from 5% to 4% of outstanding shares, a modest reduction in future equity compensation capacity.
Risk Factors
- The 27.3 million 'against' votes on the equity plan (29% of votes cast) indicate notable shareholder dissent on compensation structure.
- No financial results or guidance were provided in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-277511 |
| Document: d103876d8k.htm | 0001193125-26-277511 |
| Document: 0001193125-26-277511-index-headers.html | 0001193125-26-277511 |
| Document: 0001193125-26-277511-index.html | 0001193125-26-277511 |
| Document: 0001193125-26-277511.txt | 0001193125-26-277511 |
Track record
12 reports on ORIC
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today Press Release Neutral 5/10 Entry $7.52 Now $7.52 −0.00% settles Nov 24
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $7.59 Now $7.52 −0.92% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $7.72 Now $7.52 −2.59% settles Nov 23
- Nov 9, 20267d ago Institutional Cluster Mixed 3/10 Entry $8.91 Now $7.52 −15.60% settles Nov 17
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $13.17 to $9.24 Now $7.52 −42.90% ▼ −29.84% −29.28% vs SPY
- Oct 5, 20266w ago Press Release Bullish 6/10 Entry $11.98 to $11.31 Now $7.52 −37.23% ▼ −5.59% −5.45% vs SPY
- Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $12.49 to $11.81 Now $7.52 −39.79% ▼ −5.44% −5.87% vs SPY
- Aug 3, 202615w ago Press Release Neutral 5/10 Entry $13.47 to $13.73 Now $7.52 −44.17% ▲ +1.93% +2.03% vs SPY
- Jun 22, 202621w ago 8-K Neutral 3/10 Viewing Entry $8.91 to $10.16 Now $7.52 −15.60% ▲ +13.97% +12.96% vs SPY
- Jun 11, 202622w ago Institutional Cluster Neutral 3/10 Entry $7.82 to $8.63 Now $7.52 −3.84% ▲ +10.36% +9.92% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers